IMI publishes articles about the progress of c4c and closing the gap in paediatric medicine development
The Innovative Medicines Initiative (IMI) who provide grant funding for conect4children, have published an article about the important work c4c has carried out so far, to ensure that clinical trial sites across Europe are ‘trial ready’ for paediatric clinical trials.
The article focuses on the progress of the proof of viability studies and the purpose of the expert groups, to provide advice to clinical trial sponsors on specific aspects of their paediatric development programme or study.
To view the article in full, please click here.
IMI recognises the importance of networks like c4c, a collaboration of both the public and private sector, in improving and providing the infrastructure to carry out paediatric clinical trials, with the aim of providing high quality medicines for all children.
IMI discuss the impact of networks like c4c and the oncology project ITCC-P4 on the development of paediatric medicines in their article ‘It’s time to close the paediatric gap’. To view the article in full, please click here